mercredi 30 septembre 2026
RechercherExplore
fr.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 19, 2026

The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond

View original at nasdaq.com
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond Key Points AbbVie provides an attractive combination of income, value, and growth…
Opening lines of the source · short snapshot — read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AbbVie should deliver solid growth over the next few years driven by drugs like Rinvoq and Skyrizi and promising late-stage pipeline programs

    60% confidence

  • The 10 stocks identified by Stock Advisor could produce monster returns in the coming years

    60% confidence

  • Now is a great time to invest in dividend stocks with above-average yields

    60% confidence

  • Realty Income has particularly promising opportunities in Europe, where the total addressable market is $8.5 trillion and competition is limited

    60% confidence

  • Enbridge expects to deliver growth across all aspects of its business, especially in natural gas transmission

    60% confidence

  • The Federal Reserve is virtually paralyzed by uncertainty about inflation and the job market

    60% confidence

  • Enbridge has visible growth through the end of the decade, with roughly $50 billion of opportunities identified

    60% confidence

Data points we hold from this source

S&P 500 · healthcare sector forward pe ratio17.4 ratio
S&P 500 · forward pe ratio20 ratio
AbbVie Inc. · dividend increase streak53 years
AbbVie Inc. · forward pe ratio14.3 ratio
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
The Agentic Takeover of the CFO's Office
Enterprise finance software vendors—BlackLine, OneStream, Numero AI, and Oracle—are racing to embed autonomous AI agents into core financial operations (close, consolidation, reporting), backed by consolidation M&A (Numero-Royu, BlackLine-WiseLayer), fresh leadership hires, and survey data showing nearly a quarter of CFOs plan to boost AI spending over 50%. Adoption momentum is strong even as at least one bellwether (Oracle) sees its stock lag year-to-date, suggesting the market hasn't yet fully priced in the shift from AI-as-feature to AI-as-agent in finance.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Morgan Stanley & Co. LLC
Two significantly different EPS values (10.21 vs 2.68 USD_per_share) are reported for Morgan Stanley on the same observation date (2025-12-31). Fact A specifies FY 2025, while Fact B's 'N/A' fiscal period is ambiguous. If both represent FY 2025 annual EPS, these values directly conflict. The magnitude of the difference (3.8x) is too large to attribute to rounding or minor calculation variations. The missing fiscal period in Fact B raises data quality concerns, but same-date observation + same attribute should reference the same period.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,984
faits reliés à leur source — et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,984 faits vérifiés avec la source5,315 documents sources archivés
Interrogez ces données → isubstrate.com
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond — Source | Via News | fr.VIA.NEWS